Related Experiment Video
Updated: Oct 5, 2025
07:22
Quality-Controlled Sputum Analysis by Flow Cytometry
Published on: August 9, 2021
5.3K
Contemporary Challenges in Clinical Flow Cytometry: Small Samples, Big Data, Little Time
Jonathan R Brestoff1, John L Frater1
1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
The Journal of Applied Laboratory Medicine
|January 21, 2022
Summary
Flow cytometry analysis for hematologic diseases faces challenges with low cell counts and data volume. Emerging technologies and AI-driven analysis improve diagnostic accuracy and efficiency in clinical settings.
Area of Science:
- Clinical laboratory science
- Hematology
- Immunophenotyping
Background:
- Flow cytometry is crucial for diagnosing and monitoring hematologic diseases.
- Suboptimal cell counts and viability lead to analysis failures.
- High-dimensional data from flow cytometry presents analysis and reporting challenges.
Purpose of the Study:
- To review current and emerging technologies for cell analysis in clinical flow cytometry.
- To discuss innovations in data analysis, including artificial intelligence.
- To highlight improvements optimizing clinical flow cytometry quality.
Main Methods:
- Conventional multicolor flow cytometry.
- High-dimensional technologies: spectral flow cytometry and mass cytometry.
- Artificial intelligence-aided data analysis techniques.
Main Results:
- New technologies enable multiparameter analysis of challenging specimens (low cell counts, low viability).
- High-dimensional methods allow simultaneous detection of over 40 antigens.
- AI enhances flow cytometry data analysis and reporting.
Conclusions:
- Technological advancements and data analysis innovations optimize clinical flow cytometry quality.
- These improvements are vital for the expanding role of flow cytometry in patient care.
- Enhanced flow cytometry supports accurate diagnosis and disease monitoring.
